COMIRNATY KP.2 10 micrograms / dose dispersion for injection children 5 to 11 years
- Licence status
- Active substances
- Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2
- Dosage Form
- Dispersion for injection
- Licence number
- EU/1/20/1528/040-041
- Licence holder
- BioNTech Manufacturing GmbH
Product documents
Licence information
- ATC code
- J07BN01 covid-19, RNA-based vaccine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 21/12/2020